Shikimate pathway

Can B Corp. Secures Ownership and Control of Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million

Retrieved on: 
Monday, March 11, 2024
OTCQB, Cancer, Anxiety, THCA, Shikimate pathway, Growth, CBN, Cannabinoid, European, Health, Ground substance, Chronic pain, Patent, Federal court, THC, PTSD, Cannabis, Sleep, IBS, Controlled Substances Act, Pharmaceutical industry

HICKSVILLE, NY, March 11, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Can B Corp., a Florida corporation (OTCQB: CANB) (“Can B”), a health and wellness company specializing in developing, producing and selling hemp-derived cannabinoid products, is pleased to announce that it has secured ownership and control of two cannabis patents that were valued at $122 million, applying a 90% discount and assuming a revenue stream through August 2034, and further based on only CBD claims and only in the U.S. It is believed that if the global THC and CBD markets were added to the valuation, then the value of the patents is potentially up to $750 million.

Key Points: 
  • It is believed that if the global THC and CBD markets were added to the valuation, then the value of the patents is potentially up to $750 million.
  • These patents were previously awarded to United Cannabis Corporation and recently assigned to Can B by a court procedure.
  • The patents were valued at $122 million in December 2020 by an independent third-party valuation team, which used a 90% discount rate due to the emerging nature of the industry.
  • We believe there is a strong opportunity to monetize these patents as they represent important innovations in this industry.

Vivimu Unveils Groundbreaking Compassionate Care Initiative: A 1 Billion MG Hemp-Derived Cannabinoid Giveaway Program

Retrieved on: 
Monday, October 2, 2023
Heart, Partnership, Cannabinoid, 1 Billion Views, Wild, Medicine, Hospital, Cannabis, Shikimate pathway, Health, Pharmaceutical industry, Drug, Dum vivimus vivamus

GOLDEN, Colo., Oct. 02, 2023 (GLOBE NEWSWIRE) -- In a bold move to democratize access to quality hemp-derived products, Vivimu.com has unveiled its "1 Billion MG Compassionate Care Initiative".

Key Points: 
  • GOLDEN, Colo., Oct. 02, 2023 (GLOBE NEWSWIRE) -- In a bold move to democratize access to quality hemp-derived products, Vivimu.com has unveiled its "1 Billion MG Compassionate Care Initiative".
  • This program invites everyone to experience Vivimu’s premium cannabinoid isolates, including CBD Isolate, CBN Isolate, CBDa Isolate, and CBG Isolate for free.
  • With the '1 Billion MG Compassionate Care Initiative', we aim to extend the holistic advantages of our cannabinoid products to a broader audience, ensuring that more individuals can embark on a journey of enhanced well-being."
  • Contact us today to explore partnership opportunities and be a driving force behind the Billion Gram Giveaway.

Myotonic Dystrophy Drug Pipeline Research Report 2023: Comprehensive Insights About 20+ Companies and 22+ Pipeline Drugs - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 14, 2023
General Health, Pharmaceutical, Health, Other Health, Muscular dystrophy, GSK3, Therapy, Tideglusib, DM1, European Medicines Agency, Clinical trial, Histamine, NDA, Shikimate pathway, CNS, Messenger, II, EMA, Discovery, Patient, H3, DMPK, Mergers and acquisitions, ASO, Phase, News, Dyne, Disease, Pharmaceutical industry, Vaccine, Myotonic dystrophy, Myotonia

The "Myotonic Dystrophy - Pipeline Insight, 2023" report offers an extensive overview of the Myotonic Dystrophy pipeline landscape, featuring insights on over 20 companies and 22 pipeline drugs.

Key Points: 
  • The "Myotonic Dystrophy - Pipeline Insight, 2023" report offers an extensive overview of the Myotonic Dystrophy pipeline landscape, featuring insights on over 20 companies and 22 pipeline drugs.
  • For a holistic understanding, it includes a detailed disease overview and Myotonic Dystrophy treatment guidelines.
  • Currently, the drug is being investigated in the Phase II/III stage of clinical trial evaluation for the treatment of Congenital Myotonic Dystrophy.
  • This segment of the report provides insights about the different Myotonic Dystrophy drugs segregated based on following parameters that define the scope of the report, such as:
    There are approx.

Second Annual CA State Fair Cannabis Competition Announces Award Winners

Retrieved on: 
Thursday, June 22, 2023
Entertainment, Cannabis, Events, Concerts, Specialty, Agriculture, State, Local, Natural Resources, Retail, Marketing, Communications, Alternative Medicine, Health, Public Policy, Government, Soma, Mendocino, Golden Bear, Partnership, Eureka, Genetics, Friends, Farmer, Myrcene, California State Fair, Terpene, State Fair, Cannabinoid, History, Science, Creativity, Molecular genetics, Gold, THCA, Housekeeping, Shikimate pathway, California Exposition, Good Housekeeping, Felony, Film industry, Drug, Limonene

The CA State Fair Cannabis Awards today announced this year’s award-winning cultivars and cultivators from throughout California.

Key Points: 
  • The CA State Fair Cannabis Awards today announced this year’s award-winning cultivars and cultivators from throughout California.
  • “This second annual CA State Fair Cannabis Competition has highlighted the meticulous dedication, skill, and creativity of the cannabis growers in our state,” said Tom Martinez, CEO of Cal Expo and California State Fair.
  • This award is the equivalent to the Good Housekeeping seal of approval, which will energize our marketing and lift our brand.”
    All award winners will be celebrated and showcased at the CA Cannabis Exhibit at the CA State Fair from July 14-30, 2023, at the Cal Expo Fairgrounds in Sacramento, California.
  • Editor’s Note: Members of the media are invited to a media preview of the CA State Fair Cannabis Exhibit Experience on Wednesday, July 12, and the CA State Fair Cannabis Awards Ceremony on Saturday, July 15.

Hemp, Inc. (HEMP) Discusses Significance of Its Potential Partnership With an A-List Celebrity's CBD Skin Care Product Line with The Stock Day Podcast

Retrieved on: 
Thursday, March 9, 2023
Shikimate pathway, Sale, MTC, Coronavirus, Partnership, Organization, CVC, COVID-19, History, Hemp, Marketing, CBG, CBN, Interview, Organic, System, OTC Markets Group, Dietary supplement, CBD

The CVC of the Company, Bruce Perlowin, joined Stock Day host Everett Jolly.

Key Points: 
  • The CVC of the Company, Bruce Perlowin, joined Stock Day host Everett Jolly.
  • "I am a visionary; we were the first publicly traded company in the hemp industry," he shared.
  • "So, I spearhead the direction of the company in a very creative and cutting edge way."
  • Jolly then noted the Company's partnership with an A-list celebrity's six phase skin care line.

Hemp, Inc. to Collaborate with Cardi B's New Six-Phase Skincare Line Kulture Wave Beauty (KWB)

Retrieved on: 
Thursday, March 2, 2023
Cream, Face, Woman, Sleep hygiene, MCT, Cardi, Vine, Research, Guinness, WAP, Cardi B, ASCAP, KWB, CBN, Skin care, Female, History, Music, BET Hip Hop Awards, Skin, News, Rihanna, Hyperpigmentation, BET Awards, Coffee, CBD, Album of the Year, Woman of the Year, OTC, Shikimate pathway, Dermatology, Social media, MTV Video Music Awards, CBG, Dream, Billboard Women in Music, Breakout (Miley Cyrus song), Organic, Partnership, American Music Awards, Cosmetics

The skincare and feminine hygiene products, in the line, include CBD as a key ingredient.

Key Points: 
  • The skincare and feminine hygiene products, in the line, include CBD as a key ingredient.
  • Kulture Wave Beauty (KWB) is a six-phase beauty line scientifically formulated by leading scientists and dermatologists to promote glowing, radiant skin for all skin types.
  • Cardi B is joining the ranks of beauty moguls such as Rihanna, Kylie Jenner, and Kim Kardashian with Kulture Wave Beauty (KWB).
  • We don’t know but with Cardi B's passion for empowering women and Hemp, Inc.'s industry expertise, Kulture Wave Beauty is poised to make a significant impact on the beauty industry nonetheless.

Global Cannabidiol Market 2022 to 2031 - Featuring Folium Biosciences, Elixinol, NuLeaf Naturals and Isodiol International Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, January 6, 2023
Chemicals, Plastics, Natural Resources, Cannabis, Manufacturing, Benchmark, SAS, Anxiety, Coronavirus, Pain, Therapeutic Goods Administration, CBN, Public health, Epilepsy, Organization, Pharmacy, Sleep, Dystonia, Shikimate pathway, Cannabidiol, Growth, Tablet, Hyco International Inc, Acquisition, CBC, Capsule, Create, Appetite, Coffee, CBG, Cannabis, Cannabis sativa, Crohn's disease, Parkinson's disease, Marketing, Dietary supplement, CBD

The cannabidiol market consists of sales of cannabidiol products by entities (organizations, sole traders, and partnerships) is defined as a chemical compound found in hemp or marijuana.

Key Points: 
  • The cannabidiol market consists of sales of cannabidiol products by entities (organizations, sole traders, and partnerships) is defined as a chemical compound found in hemp or marijuana.
  • The rising acceptance and use of CBD products due to government approvals are expected to propel the growth of the cannabidiol market.
  • Therefore, the rising acceptance and use of CBD products due to government approvals are driving the growth of the cannabidiol market.
  • The countries covered in the cannabidiol market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

Sisters of the Valley Add Artificial Intelligence to Webstore

Retrieved on: 
Thursday, November 24, 2022
CBC, CBN, Hand, Valley, Learning, Cannabis, Medicine, Shikimate pathway, Holiday, FAQ, Sister, Intelligence, Moon, Sisters of the Valley, Online shopping, Medicinal plants

Merced, California, Nov. 24, 2022 (GLOBE NEWSWIRE) -- The Sisters of the Valley took another big step that improves the website experience of their customers by launching an artificial intelligence bot to help people figure out what products are most suitable to their specific needs.

Key Points: 
  • Merced, California, Nov. 24, 2022 (GLOBE NEWSWIRE) -- The Sisters of the Valley took another big step that improves the website experience of their customers by launching an artificial intelligence bot to help people figure out what products are most suitable to their specific needs.
  • Powered by Envolve Tech , a U.K. company, the Sisters just launched their virtual assistant in time for the holidays.
  • The Sisters of the Valley make all their products by the cycles of the moon, by hand, and in a spiritual environment.
  • Every batch is tested by SC Labs, the test results accompany all products, and the products ship worldwide.

Open Book Extracts Receives Strategic Investment from Btomorrow Ventures as Lead Investor in Series C Financing

Retrieved on: 
Thursday, September 15, 2022
OBX, American Tobacco Company, Tablet, Safety, Tetrahydrocannabivarin, Cannabinoid, ISO 9001, CBG, BAT, BTV, NSF, CBD, Research Triangle, CBN, CBT, Review, Cannabidivarin, Toxicology, IP, Capsule, CBC, Shikimate pathway, British American Tobacco, Doctor of Philosophy, Method, Softgel, Research, ISO, Drink, Innovation, Pharmaceutical industry, Dietary supplement, Fine chemical

ROXBORO, N.C., Sept. 15, 2022 /PRNewswire/ -- Open Book Extracts (OBX), a leading global ingredient manufacturer and product development house for the industry's most innovative and highest quality cannabinoid-enabled products, today announces the completion of its Series C financing round.

Key Points: 
  • ROXBORO, N.C., Sept. 15, 2022 /PRNewswire/ -- Open Book Extracts (OBX), a leading global ingredient manufacturer and product development house for the industry's most innovative and highest quality cannabinoid-enabled products, today announces the completion of its Series C financing round.
  • The funding secured could total between $20 million and $25 million (dependent upon achieving certain milestones).
  • In addition to the funding, OBX and BAT have also signed a scientific collaboration agreement covering certain areas of future R&D.
  • Established in 2020, BTV invests in high growth businesses, from seed funding to those looking for further, series B investment.

CaviCann Announces New Vice President of Sales, Launch of New Industry-Leading Hemp-Derived Drink Mixes

Retrieved on: 
Thursday, September 15, 2022
THC, ECS, United States farm bill, Delta, Cannabinoid, CBG, 2018 United States farm bill, Learning, Industry, Space Delta 9, Sullivan University, GLOBE, Delta-8-Tetrahydrocannabinol, M.B.A, Marketing, Soft drink, Coffee, CBD, Shikimate pathway

With the addition of Adair, CaviCann announces their new line ofhemp-derived drink mixes that are taking the industry by storm.

Key Points: 
  • With the addition of Adair, CaviCann announces their new line ofhemp-derived drink mixes that are taking the industry by storm.
  • CaviCann has a proprietary blend of their 4C Total Cannabinoid profile that is higher in CBDa, CBGa, CBD, and CBG .
  • The best part about these new drink mixes is that they're federally legal in the United States per the Farm Bill of 2018.
  • For more information regarding these drink mixes and other products from CaviCann, please visit https://www.cavicann.com .